We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
(+5%)
Cap. Flow
+$6.41B
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.02B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$944M |
| 3 |
AT&T
T
|
+$753M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$553M |
| 5 |
Linde
LIN
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$331M |
| 2 |
FDC
First Data Corporation
FDC
|
+$331M |
| 3 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$312M |
| 4 |
Blackstone
BX
|
+$277M |
| 5 |
FirstEnergy
FE
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.59% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.31% |
| 4 | Consumer Discretionary | 6.45% |
| 5 | Communication Services | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Invesco
IVZ
$13.1B
| $18.1M | 0.02% |
1,067,045
+410,820
| +63% | +$7.25M |
|
977
Regions Financial
RF
$26.4B
| $18M | 0.02% |
1,136,666
-52,718
| -4% | -$797K |
|
|
MMP
978
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $17.9M | 0.02% |
270,690
+126,437
| +88% | +$8.32M |
|
979
Devon Energy
DVN
$52.1B
| $17.9M | 0.02% |
745,131
-478,695
| -39% | -$12M |
|
|
IRBT
980
PUT
DELISTED
iRobot
IRBT
| $17.9M | 0.02% |
290,000
+190,000
| +190% | +$13.6M |
|
|
KYNB
981
Kyntra Bio
KYNB
$27.2M
| $17.9M | 0.02% |
19,329
-1,337
| -6% | -$1.47M |
|
982
PUT
Franco-Nevada
FNV
$41.1B
| $17.9M | 0.02% |
196,000
| – | – |
|
983
Carlyle Group
CG
$16.6B
| $17.8M | 0.02% |
695,947
+638,324
| +1,108% | +$15.3M |
|
984
iShares Dow Jones US ETF
IYY
$2.95B
| $17.7M | 0.01% |
239,900
+200,346
| +507% | +$14.7M |
|
985
Perrigo
PRGO
$1.4B
| $17.7M | 0.01% |
315,992
+427
| +0.1% | +$21.7K |
|
986
Melco Resorts & Entertainment
MLCO
$2.22B
| $17.6M | 0.01% |
909,085
+439,462
| +94% | +$9.54M |
|
987
Lear
LEA
$6.54B
| $17.6M | 0.01% |
149,532
-4,965
| -3% | -$604K |
|
988
PUT
Halliburton
HAL
$26.9B
| $17.6M | 0.01% |
935,000
-520,000
| -36% | -$10.8M |
|
989
Unum
UNM
$13.6B
| $17.6M | 0.01% |
591,761
+59,988
| +11% | +$1.78M |
|
|
BERY
990
DELISTED
Berry Global Group, Inc.
BERY
| $17.6M | 0.01% |
487,373
+351,610
| +259% | +$14.4M |
|
991
Omega Healthcare
OHI
$15.1B
| $17.5M | 0.01% |
419,773
-31,105
| -7% | -$1.21M |
|
992
SiriusXM
SIRI
$9.98B
| $17.5M | 0.01% |
280,211
+62,428
| +29% | +$3.84M |
|
993
CALL
Align Technology
ALGN
$12.1B
| $17.5M | 0.01% |
96,800
+6,600
| +7% | +$1.37M |
|
994
Lincoln National
LNC
$8.73B
| $17.5M | 0.01% |
290,026
-38,361
| -12% | -$2.29M |
|
995
Teledyne Technologies
TDY
$30.4B
| $17.5M | 0.01% |
54,267
+4,683
| +9% | +$1.4M |
|
|
PBCT
996
DELISTED
People's United Financial Inc
PBCT
| $17.5M | 0.01% |
1,117,269
+83,490
| +8% | +$1.31M |
|
|
CZR
997
DELISTED
Caesars Entertainment Corporation
CZR
| $17.5M | 0.01% |
1,497,053
+454,910
| +44% | +$5.33M |
|
998
Domino's
DPZ
$11.5B
| $17.4M | 0.01% |
71,025
+11,770
| +20% | +$2.92M |
|
999
Regenxbio
RGNX
$620M
| $17.4M | 0.01% |
487,854
-6,661
| -1% | -$270K |
|
1000
EPAM Systems
EPAM
$5.51B
| $17.3M | 0.01% |
95,148
-28,668
| -23% | -$5.4M |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q3 2019 Portfolio in Review
As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.
- Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
- Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
- Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
- Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
- Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
- Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
- Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.
Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.